Glaucoma laser from Quantel Medical cleared by FDA

Ophthalmic ultrasound and laser device maker Quantel Medical (Clermont-Ferrand, France) has received FDA approval for its Solutis glaucoma laser. The approval follows the expiration of a patent issued to Massachusetts General Hospital (Boston, MA), which restricted the company and several other laser manufacturers from marketing selective laser trabeculoplasty (SLT) technology within the U.S. The company has been providing SLT technology to customers outside the U.S. since 2007.

Related: Novel ophthalmic imaging with adaptive optics, confocal imaging, and OCT

Related: Laser cataract surgery: Clearly advanced

SLT is a first-line and adjunct therapy option for reducing intraocular pressure (IOP) in glaucoma patients. The noninvasive procedure delivers targeted laser energy, inducing a regenerative response at the cellular level. Due to the laser energy’s gentle application, the treatment is repeatable and not associated with the ocular and systemic side effects or compliance issues commonly linked to glaucoma drugs.

The Solutis laser's design is adaptable to a physician's current slit lamp, eliminating the need for dedicated space and lowering end-user cost. It is also transportable from room to room or office to office, and includes storage accessories when not in use.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

 

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World